Forcyte Biotechnologies

Discover drugs that control how much cells "squeeze" to treat disease

Los Angeles, United States · Founded 2017

Employees
1–10
Founded
2017
Last Round
SeedJun 2022
Rounds
2

About

In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.

Summary

Forcyte Biotechnologies is a Drug Discovery company based in Los Angeles, United States, founded in 2017. Its most recent funding was a Seed round in Jun 2022. Investors include Y Combinator Continuity Fund, Pioneer Fund and Acequia Capital.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundJun 2022

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies